{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:47:48Z","timestamp":1791863268715,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.nano.2026.103020","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:39:39Z","timestamp":1788590379000},"page":"103020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineering extracellular vesicles for targeted siRNA delivery: Advances, therapeutic applications, and clinical translation"],"prefix":"10.1016","volume":"77","author":[{"given":"G.S. Amrish","family":"Varshan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Karthick Raja","family":"Namasivayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nano.2026.103020_bb0005","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ymthe.2021.01.015","article-title":"siRNA drugs: Here to stay","volume":"29","author":"Rossi","year":"2021","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12929-023-00981-9","article-title":"Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges","volume":"30","author":"Kang","year":"2023","journal-title":"J Biomed Sci"},{"issue":"5","key":"10.1016\/j.nano.2026.103020_bb0015","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1021\/acs.accounts.9b00079","article-title":"Bioinspired and biomimetic nanomedicines","volume":"52","author":"Chen","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.nano.2026.103020_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.734720","article-title":"Development of extracellular vesicle therapeutics: challenges, considerations, and opportunities","volume":"9","author":"Claridge","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.nano.2026.103020_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2022.102776","article-title":"Manufactured extracellular vesicles as human therapeutics: challenges, advances, and opportunities","volume":"77","author":"Estes","year":"2022","journal-title":"Curr Opin Biotechnol"},{"issue":"9","key":"10.1016\/j.nano.2026.103020_bb0030","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.7150\/thno.131621","article-title":"From bench to bedside: the promise and roadblocks of extracellular vesicle therapeutics","volume":"16","author":"Zhang","year":"2026","journal-title":"Theranostics"},{"issue":"6478","key":"10.1016\/j.nano.2026.103020_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/10717544.2020.1748758","article-title":"Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source","volume":"27","author":"Meng","year":"2020","journal-title":"Drug Deliv"},{"issue":"5","key":"10.1016\/j.nano.2026.103020_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101202","article-title":"Functional siRNA delivery by extracellular vesicle\u2013liposome hybrid nanoparticles","volume":"11","author":"Evers","year":"2022","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/0115665232357160250123113148","article-title":"Targeting Undruggable proteins: the siRNA revolution beyond small molecules - advances, challenges, and future prospects in therapeutic innovation","volume":"26","author":"Jan","year":"2026","journal-title":"Curr Gene Ther"},{"issue":"5","key":"10.1016\/j.nano.2026.103020_bb0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40259-022-00549-3","article-title":"Therapeutic siRNA: state-of-the-art and future perspectives","volume":"36","author":"Friedrich","year":"2022","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","article-title":"Current advance of nanotechnology in diagnosis and treatment for malignant tumors","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12575-024-00241-6","article-title":"MicroRNA Nano-shuttles: engineering extracellular vesicles as a cutting-edge biotechnology platform for clinical use in therapeutics","volume":"26","author":"Menjivar","year":"2024","journal-title":"Biological Procedures Online"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0080","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1186\/s12951-024-02972-w","article-title":"Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach","volume":"22","author":"Haghighi","year":"2024","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.nano.2026.103020_bb0090","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.addr.2020.06.020","article-title":"Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles","volume":"156","author":"Luther","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0095","doi-asserted-by":"crossref","DOI":"10.1515\/ntrev-2023-0158","article-title":"Cell type-targeting nanoparticles in treating central nervous system diseases: challenges and hopes","volume":"12","author":"Guo","year":"2023","journal-title":"Nanotechnol Rev"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-021-00631-2","article-title":"Recent progress in targeted delivery vectors based on biomimetic nanoparticles","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-023-02275-6","article-title":"Synergistic vesicle-vector systems for targeted delivery","volume":"22","author":"Marquez","year":"2024","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010038","article-title":"Optimised electroporation for loading of extracellular vesicles with doxorubicin","volume":"14","author":"Lenna\u00e1rd","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.103020_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1298746","article-title":"Emerging technologies for engineering of extracellular vesicles","volume":"11","author":"Zhou","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0125","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12951-023-02081-0","article-title":"Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification","volume":"21","author":"Liu","year":"2023","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"10.1016\/j.nano.2026.103020_bb0130","article-title":"Advances in extracellular vesicle nanotechnology for precision theranostics","volume":"10","author":"Wu","year":"2023","journal-title":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s40820-022-00922-5","article-title":"Importance of standardizing analytical characterization methodology for improved reliability of the nanomedicine literature","volume":"14","author":"Sharifi","year":"2022","journal-title":"Nano Micro Lett"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0140","article-title":"CRISPR\/Cas9 therapeutics: progress and prospects","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.nano.2026.103020_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126147","article-title":"CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy","volume":"250","author":"Liu","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-025-02368-w","article-title":"Nanomedicine in Cancer therapeutics: current perspectives from bench to bedside","volume":"24","author":"Abdullah","year":"2025","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/17425247.2024.2440099","article-title":"Extracellular nanovesicles as neurotherapeutics for central nervous system disorders","volume":"22","author":"Bhom","year":"2025","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"10.1016\/j.nano.2026.103020_bb0160","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","article-title":"Recent advances in extracellular vesicles for therapeutic cargo delivery","volume":"56","author":"Kim","year":"2024","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41536-021-00132-4","article-title":"Small extracellular vesicles derived from interferon-\u03b3 pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis","volume":"6","author":"Takeuchi","year":"2021","journal-title":"npj Regener Med"},{"key":"10.1016\/j.nano.2026.103020_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2022.913225","article-title":"On-demand drug delivery: recent advances in cardiovascular applications","volume":"2","author":"Gen\u00e7","year":"2022","journal-title":"Frontiers in Drug Delivery"},{"issue":"4","key":"10.1016\/j.nano.2026.103020_bb0175","article-title":"Bacterial extracellular vesicles and antimicrobial peptides: a synergistic approach to overcome antimicrobial resistance","volume":"14","author":"Ciobanasu","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.nano.2026.103020_bb0180","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.2147\/IJN.S464249","article-title":"Engineering exosomes for therapeutic applications: decoding biogenesis, content modification, and cargo loading strategies","volume":"19","author":"Bahadorani","year":"2024","journal-title":"Int J Nanomedicine"},{"issue":"11","key":"10.1016\/j.nano.2026.103020_bb0185","doi-asserted-by":"crossref","first-page":"10313","DOI":"10.1021\/acsnano.3c00668","article-title":"Delivery of engineered primary tumor-derived exosomes effectively suppressed the colorectal Cancer Chemoresistance and liver metastasis","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.nano.2026.103020_bb0190","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41565-024-01785-0","article-title":"Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes","volume":"19","author":"Zhuo","year":"2024","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-63718-2","article-title":"Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlates","volume":"16","author":"Kalluri","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.103020_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2025.1675209","article-title":"Advances in RNA-based therapeutics: current breakthroughs, clinical translation, and future perspectives","volume":"16","author":"Makkar","year":"2025","journal-title":"Front Genet"},{"issue":"D1","key":"10.1016\/j.nano.2026.103020_bb2000","doi-asserted-by":"crossref","first-page":"D442","DOI":"10.1093\/nar\/gkad1058","article-title":"ELM\u2014the Eukaryotic Linear Motif resource\u20142024 update","volume":"52","author":"Kumar","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb2005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41467-020-20226-9","article-title":"Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom","volume":"12","author":"Murphy","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.nano.2026.103020_bb2010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jum.16611","article-title":"Overview of therapeutic ultrasound applications and safety considerations: 2024 update","volume":"44","author":"Bader","year":"2025","journal-title":"J Ultrasound Med"},{"issue":"6","key":"10.1016\/j.nano.2026.103020_bb2015","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s10661-023-11191-z","article-title":"Multi-temporal Landsat imagery and MSAVI index for monitoring rangeland degradation in arid ecosystem, case study of Biskra (southeast Algeria)","volume":"195","author":"Belhadj","year":"2023","journal-title":"Environ Monit Assess"},{"issue":"24","key":"10.1016\/j.nano.2026.103020_bb2020","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1002\/smll.201600393","article-title":"Identification of individual exosome\u2010like vesicles by surface enhanced raman spectroscopy","volume":"12","author":"Stremersch","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.nano.2026.103020_bb2025","series-title":"Improving Factuality and Reasoning in Language Models Through Multiagent Debate","author":"Du","year":"2023"},{"issue":"19","key":"10.1016\/j.nano.2026.103020_bb2030","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1002\/ece3.3315","article-title":"Secondary invasion: when invasion success is contingent on other invaders altering the properties of recipient ecosystems","volume":"7","author":"O'Loughlin","year":"2017","journal-title":"Ecol Evol"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb2035","doi-asserted-by":"crossref","DOI":"10.5943\/mycosphere\/15\/1\/25","article-title":"The 2024 outline of fungi and fungus-like taxa","volume":"15","author":"Hyde","year":"2024","journal-title":"Mycosphere"},{"issue":"2","key":"10.1016\/j.nano.2026.103020_bb2040","doi-asserted-by":"crossref","first-page":"L34","DOI":"10.3847\/2041-8213\/ac9b2a","article-title":"On the sound speed in neutron stars","volume":"939","author":"Altiparmak","year":"2022","journal-title":"Astrophys J Lett"},{"issue":"D1","key":"10.1016\/j.nano.2026.103020_bb2045","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","article-title":"miRTarBase update 2022: an informative resource for experimentally validated miRNA\u2013target interactions","volume":"50","author":"Huang","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.nano.2026.103020_bb2050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10308-025-00746-z","article-title":"Subnational dimensions of the EU\u2019s de-risking strategy in relations with China","volume":"23","author":"Kami\u0144ski","year":"2025","journal-title":"Asia Eur J"},{"key":"10.1016\/j.nano.2026.103020_bb2055","doi-asserted-by":"crossref","first-page":"87310","DOI":"10.52202\/079017-2771","article-title":"Cambrian-1: a fully open, vision-centric exploration of multimodal llms","volume":"37","author":"Tong","year":"2024","journal-title":"Adv Neural Inf Proces Syst"},{"issue":"4","key":"10.1016\/j.nano.2026.103020_bb2060","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41591-022-01765-8","article-title":"Engineered cellular immunotherapies in cancer and beyond","volume":"28","author":"Finck","year":"2022","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.nano.2026.103020_bb2065","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41591-023-02702-z","article-title":"A deep learning system for predicting time to progression of diabetic retinopathy","volume":"30","author":"Dai","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2026.103020_bb2070","series-title":"2024 27th International Conference on Electrical Machines and Systems (ICEMS)","first-page":"3628","article-title":"Development of a bearingless pm motor with axial magnetic suspension using zero-sequence current","author":"Fujii","year":"2024"},{"key":"10.1016\/j.nano.2026.103020_bb2075","article-title":"Comprehensive analysis of CRISPR-Cas systems and their influence on antibiotic resistance in Salmonella enterica strains","volume":"18","author":"Fallah","year":"2024","journal-title":"Bioinf Biol Insights"},{"issue":"5","key":"10.1016\/j.nano.2026.103020_bb2080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/3735633","article-title":"Continual learning of large language models: a comprehensive survey","volume":"58","author":"Shi","year":"2025","journal-title":"ACM Comput Surv"},{"issue":"2","key":"10.1016\/j.nano.2026.103020_bb2085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/ggi.14322","article-title":"An update on cognitive frailty: its definition, impact, associated factors and underlying mechanisms, and interventions","volume":"22","author":"Sugimoto","year":"2022","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"10.1016\/j.nano.2026.103020_bb2090","doi-asserted-by":"crossref","DOI":"10.1080\/14786451.2024.2417436","article-title":"Advancing sustainable energy: a systematic review of geothermal-powered district heating and cooling networks","volume":"43","author":"Kassem","year":"2024","journal-title":"Int J Sustain Energy"},{"issue":"4","key":"10.1016\/j.nano.2026.103020_bb2095","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1007\/s00210-024-03547-0","article-title":"A comprehensive review on the green synthesis of silver nanoparticles from marine sources","volume":"398","author":"Palanisamy","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"10","key":"10.1016\/j.nano.2026.103020_bb3000","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/eat.24262","article-title":"Guidelines for rigorous and reproducible research on other specified feeding or eating disorder: commentary on Dang et al.(2024)","volume":"57","author":"Keel","year":"2024","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.nano.2026.103020_bb3005","series-title":"Transfer Between Modalities With Metaqueries","author":"Pan","year":"2025"},{"issue":"4","key":"10.1016\/j.nano.2026.103020_bb3010","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.3390\/ijms27041688","article-title":"Characterization, preconditioning, safety, and other issues of MSC-derived EVs and secretome","volume":"27","author":"Alpeeva","year":"2026","journal-title":"Int J Mol Sci"},{"issue":"10480","key":"10.1016\/j.nano.2026.103020_bb3015","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(24)02842-3","article-title":"Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial","volume":"405","author":"Couturaud","year":"2025","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.nano.2026.103020_bb3020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/3703155","article-title":"A survey on hallucination in large language models: principles, taxonomy, challenges, and open questions","volume":"43","author":"Huang","year":"2025","journal-title":"ACM Trans Inf Syst"},{"key":"10.1016\/j.nano.2026.103020_bb3025","series-title":"Assessment of Soil Acidification Rates and Their Drivers Across European Croplands","author":"Roefs","year":"2025"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:29:20Z","timestamp":1791862160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426001218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":63,"alternative-id":["S1549963426001218"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.103020","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering extracellular vesicles for targeted siRNA delivery: Advances, therapeutic applications, and clinical translation","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.103020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103020"}}